Literature DB >> 17692531

mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol.

Satoru Suzuki1, Jun-Ichirou Mori, Kiyoshi Hashizume.   

Abstract

Thyroid hormone action is initiated through nuclear thyroid hormone receptors (TRs). Before the discovery of these nuclear receptors, possible major binding sites for thyroid hormones were thought to be cytosolic owing to high thyroid hormone-binding activity in crude cytosolic fractions. Several cytosolic thyroid hormone-binding proteins have been identified, including reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent 3,5,3'-triiodo-L-thyronine (T(3))-binding protein, also known as mu-crystallin, which was initially cloned as the ortholog of bacterial ornithine cyclodeaminase. The expression of mu-crystallin is developmentally regulated and cell-type specific. Recently, patients with nonsyndromic deafness were reported to have point mutations in the mu-crystallin gene. Cytosolic thyroid hormone-binding proteins, especially mu-crystallin, have roles in adaptation to environmental alterations by thyroid hormone, which might have a role in hearing function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692531     DOI: 10.1016/j.tem.2007.07.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  11 in total

1.  Microarray analysis of differentially expressed genes in the brains of tubby mice.

Authors:  Jeong Ho Lee; Chul Hoon Kim; Dong Goo Kim; Young Soo Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

Review 2.  Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

Authors:  John D Baxter; Paul Webb
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

3.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

4.  Gender-specific regulation of response to thyroid hormone in aging.

Authors:  Satoru Suzuki; Shin-Ichi Nishio; Teiji Takeda; Mitsuhisa Komatsu
Journal:  Thyroid Res       Date:  2012-01-26

5.  Hippocampal Neurogenesis Requires Cell-Autonomous Thyroid Hormone Signaling.

Authors:  Steffen Mayerl; Heike Heuer; Charles Ffrench-Constant
Journal:  Stem Cell Reports       Date:  2020-04-16       Impact factor: 7.765

6.  Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.

Authors:  Osman Aksoy; Jan Pencik; Markus Hartenbach; Ali A Moazzami; Michaela Schlederer; Theresa Balber; Adam Varady; Cecile Philippe; Pascal A Baltzer; Bismoy Mazumder; Jonathan B Whitchurch; Christopher J Roberts; Andrea Haitel; Merima Herac; Martin Susani; Markus Mitterhauser; Rodrig Marculescu; Judith Stangl-Kremser; Melanie R Hassler; Gero Kramer; Shahrokh F Shariat; Suzanne D Turner; Boris Tichy; Jan Oppelt; Sarka Pospisilova; Sabrina Hartenbach; Simone Tangermann; Gerda Egger; Heidi A Neubauer; Richard Moriggl; Zoran Culig; Georg Greiner; Gregor Hoermann; Marcus Hacker; David M Heery; Olaf Merkel; Lukas Kenner
Journal:  Int J Cancer       Date:  2020-10-31       Impact factor: 7.396

7.  Absence of Both Thyroid Hormone Transporters MCT8 and OATP1C1 Impairs Neural Stem Cell Fate in the Adult Mouse Subventricular Zone.

Authors:  Cristina Luongo; Lucile Butruille; Anthony Sébillot; Karine Le Blay; Markus Schwaninger; Heike Heuer; Barbara A Demeneix; Sylvie Remaud
Journal:  Stem Cell Reports       Date:  2021-01-14       Impact factor: 7.765

8.  Monocarboxylate transporter 8 modulates the viability and invasive capacity of human placental cells and fetoplacental growth in mice.

Authors:  Elisavet Vasilopoulou; Laurence S Loubière; Heike Heuer; Marija Trajkovic-Arsic; Veerle M Darras; Theo J Visser; Gendie E Lash; Guy S Whitley; Christopher J McCabe; Jayne A Franklyn; Mark D Kilby; Shiao Y Chan
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

Review 9.  Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.

Authors:  Tomas Jakobsson; Lise-Lotte Vedin; Paolo Parini
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

10.  Time-dependent changes in FT4 and FT3 levels measured using mass spectrometry after an acute ingestion of excess levothyroxine in a case with hypothyroidism.

Authors:  Yuko Ito; Satoru Suzuki; Yoshiko Matsumoto; Chiyo Ohkouchi; Satoshi Suzuki; Manabu Iwadate; Sanae Midorikawa; Susumu Yokoya; Shinichi Suzuki; Hiroki Shimura
Journal:  Thyroid Res       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.